Susquehanna International Group
NTRP

Susquehanna International Group’s Neurotrope, Inc. Common NTRP Stock Holding History

Susquehanna International Group’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-24,200
Closed -$20K – 11369
2020
Q1 		$20K Sell
24,200
-2,000
-8% -$2.18K ﹤0.01% 9940
2019
Q4 		$26K Sell
26,200
-9,100
-26% -$7.1K ﹤0.01% 9461
2019
Q3 		$29K Sell
35,300
-41,700
-54% -$191K ﹤0.01% 9902
2019
Q2 		$618K Buy
77,000
+60,500
+367% +$407K ﹤0.01% 6817
2019
Q1 		$90K Buy
16,500
+6,500
+65% +$27.9K ﹤0.01% 8291
2018
Q4 		$36K Buy
+10,000
New +$60.6K ﹤0.01% 8574

Other funds holding NTRP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFAS
Acorn Financial Advisory Services Reston, Virginia $753M AUM 36.94% 1-Year Est. Return
PTP
Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group's NTRP Position: Q2 2020 in Review

Susquehanna International Group sold out of Neurotrope, Inc. Common (NTRP) in Q2 2020, closing a stake of 18,084 shares — an estimated $22.6K sold.

Susquehanna International Group first reported a position in NTRP in Q4 2017 and held it in 7 quarters. The position peaked at $688K in Q2 2019. 31 funds tracked by Wall St. Rank hold NTRP as of Q2 2020.

  • Susquehanna International Group reported no remaining Neurotrope, Inc. Common position as of Q2 2020 after selling out during the quarter.
  • Susquehanna International Group sold 18,084 Neurotrope, Inc. Common shares in Q2 2020, an estimated $22.6K.
  • Susquehanna International Group first reported a position in Neurotrope, Inc. Common in Q4 2017 and held it in 7 quarters.
  • Susquehanna International Group's Neurotrope, Inc. Common position peaked at $688K in Q2 2019.
  • 31 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q2 2020.

Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.